Metabolic profiling of deschloro‐N‐ethyl‐ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high‐resolution accurate mass spectrometry
- 3 February 2021
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 13 (6), 1108-1117
- https://doi.org/10.1002/dta.3007
Abstract
The aim of this study was to identify new markers of deschloro‐N‐ethyl‐ketamine (O‐PCE), a ketamine analogue that has been involved in acute intoxications with severe outcomes including death and whose metabolism has never been studied before. In vitro study after 2‐h incubation with pooled human liver microsomes (HLMs) cross‐checked by the analysis of urine and hair from a 43‐year‐old O‐PCE user (male) were performed by liquid chromatography–high resolution mass spectrometry (LC‐HRMS). Acquired data were processed by the Compound Discoverer® software, and a full metabolic profile of O‐PCE was proposed. In total, 15 metabolites were identified, 10 were detected in vitro (HLMs) and confirmed in vivo (urine and/or hair), two were present only in HLMs, and the remaining three metabolites were identified only in biological specimens. While O‐PCE was no longer detected in urine, nine metabolites were identified allowing to increase its detection window. In descending order of metabolites abundance, we suggest using 2‐en‐PCA‐N‐Glu (34%, first), M3 (16%, second), O‐PCA‐N‐Glu (15.4%, third), OH‐O‐PCE (15%, fourth) and OH‐PCE (11.9%, fifth) as target metabolites to increase the detection window of O‐PCE in urine. In hair, nine metabolites were identified. OH‐PCA was the major compound (78%) with a relevant metabolite to parent drug ratio (=6) showing its good integration into hair and making it the best marker for long‐term monitoring of O‐PCE exposure.Keywords
This publication has 18 references indexed in Scilit:
- New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”Current Neuropharmacology, 2017
- Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass SpectrometryClinical Chemistry, 2017
- Detection of the designer benzodiazepine metizolam in urine and preliminary data on its metabolismDrug Testing and Analysis, 2016
- Principles of Drug Metabolism 3: Enzymes and Tissues☆Published by Elsevier BV ,2014
- Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamineDrug Testing and Analysis, 2013
- Merging Oxidative Dearomatization and Aminocatalysis: One-Pot Enantioselective Synthesis of Tricyclic ArchitecturesOrganic Letters, 2013
- Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MS nAnalytical and Bioanalytical Chemistry, 2013
- Determination of ketamine and norketamine in hair by micropulverized extraction and liquid chromatography–high resolution mass spectrometryForensic Science International, 2013
- In vitro approaches to studying the metabolism of new psychoactive compoundsDrug Testing and Analysis, 2011
- Taming the Ketamine TigerAnesthesiology, 2010